Primary Hyperparathyroidism in Young Adult Patients.
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
16
01
2023
accepted:
20
02
2023
medline:
12
6
2023
pubmed:
18
3
2023
entrez:
17
3
2023
Statut:
ppublish
Résumé
Primary hyperparathyroidism (PHPT) affects 2% of Americans over 55 years of age, and is less common in younger patients. Pediatric PHPT patients have higher rates of multigland disease (MGD). We studied young adult patients to determine whether they have similarly elevated rates of MGD and would benefit from routine bilateral neck exploration. Retrospective chart review was performed on patients who underwent parathyroidectomy for PHPT (2000-2019). Cohorts were defined by age: Group A (18-40 years) and Group B (> 40 years). Univariate and multivariate logistic regression analyses were performed. Of 3889 patients with PHPT, 9.1% (n = 352) were included in Group A. On multivariate analysis, multiple endocrine neoplasia (odds ratio [OR] 6.3, 95% confidence interval [CI] 3.1-12.7), male sex (OR 1.3, 95% CI 1.0-1.5), family history of PHPT (OR 2.7, 95% CI 1.6-4.8), prior parathyroidectomy (OR 2.2, 95% CI 1.6-3.0), and non-localizing imaging (OR 1.8, 95% CI 1.5-2.1) were associated with MGD; younger age was not an independent risk factor. In patients with sporadic PHPT (n = 3833), family history was most strongly associated with MGD (OR 4.0, 95% CI 2.2-7.3). In our population of patients with sporadic PHPT, a positive family history of PHPT was strongly associated with MGD; additional associations were found with prior parathyroidectomy, non-localizing imaging, and male sex. Younger age was not an independent risk factor. Age alone in the absence of a family history should not raise suspicion for MGD nor determine the need for bilateral neck exploration.
Sections du résumé
BACKGROUND
BACKGROUND
Primary hyperparathyroidism (PHPT) affects 2% of Americans over 55 years of age, and is less common in younger patients. Pediatric PHPT patients have higher rates of multigland disease (MGD). We studied young adult patients to determine whether they have similarly elevated rates of MGD and would benefit from routine bilateral neck exploration.
METHODS
METHODS
Retrospective chart review was performed on patients who underwent parathyroidectomy for PHPT (2000-2019). Cohorts were defined by age: Group A (18-40 years) and Group B (> 40 years). Univariate and multivariate logistic regression analyses were performed.
RESULTS
RESULTS
Of 3889 patients with PHPT, 9.1% (n = 352) were included in Group A. On multivariate analysis, multiple endocrine neoplasia (odds ratio [OR] 6.3, 95% confidence interval [CI] 3.1-12.7), male sex (OR 1.3, 95% CI 1.0-1.5), family history of PHPT (OR 2.7, 95% CI 1.6-4.8), prior parathyroidectomy (OR 2.2, 95% CI 1.6-3.0), and non-localizing imaging (OR 1.8, 95% CI 1.5-2.1) were associated with MGD; younger age was not an independent risk factor. In patients with sporadic PHPT (n = 3833), family history was most strongly associated with MGD (OR 4.0, 95% CI 2.2-7.3).
CONCLUSIONS
CONCLUSIONS
In our population of patients with sporadic PHPT, a positive family history of PHPT was strongly associated with MGD; additional associations were found with prior parathyroidectomy, non-localizing imaging, and male sex. Younger age was not an independent risk factor. Age alone in the absence of a family history should not raise suspicion for MGD nor determine the need for bilateral neck exploration.
Identifiants
pubmed: 36930370
doi: 10.1245/s10434-023-13344-3
pii: 10.1245/s10434-023-13344-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4156-4164Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023. Society of Surgical Oncology.
Références
Mohebati A, Shaha AR. Imaging techniques in parathyroid surgery for primary hyperparathyroidism. Am J Otolaryngol. 2012;33(4):457–68.
doi: 10.1016/j.amjoto.2011.10.010
pubmed: 22154018
Bjernulf A, Hall K, Sjögren I, Werner I. Primary hyperparathyroidism in children. Brief review of the literature and a case report. Acta Paediatr Scand. 1970;59(3):249–58.
doi: 10.1111/j.1651-2227.1970.tb09000.x
pubmed: 5424438
Mannix H Jr. Primary hyperparathyroidism in children. Am J Surg. 1975;129(5):528–31.
doi: 10.1016/0002-9610(75)90311-6
pubmed: 1130592
Girard RM, Belanger A, Hazel B. Primary hyperparathyroidism in children. Can J Surg. 1982;25(1):11–3, 32.
pubmed: 7055756
Loh KC, Duh QY, Shoback D, Gee L, Siperstein A, Clark OH. Clinical profile of primary hyperparathyroidism in adolescents and young adults. Clin Endocrinol. 1998;48(4):435–43.
doi: 10.1046/j.1365-2265.1998.00329.x
Allo M, Thompson NW, Harness JK, Nishiyama RH. Primary hyperparathyroidism in children, adolescents, and young adults. World J Surg. 1982;6(6):771–6.
doi: 10.1007/BF01655371
pubmed: 7180010
Belcher R, Metrailer AM, Bodenner DL, Stack BC Jr. Characterization of hyperparathyroidism in youth and adolescents: a literature review. Int J Pediatr Otorhinolaryngol. 2013;77(3):318–22.
doi: 10.1016/j.ijporl.2012.12.008
pubmed: 23313432
Karges W, Schaaf L, Dralle H, Boehm BO. Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1). Exp Clin Endocrinol Diabetes. 2000;108(5):334–40.
doi: 10.1055/s-2000-8146
pubmed: 10989951
Cupisti K, Raffel A, Dotzenrath C, Krausch M, Röher HD, Schulte KM. Primary hyperparathyroidism in the young age group: particularities of diagnostic and therapeutic schemes. World J Surg. 2004;28(11):1153–6.
doi: 10.1007/s00268-004-7671-2
pubmed: 15490051
Miller BS, Dimick J, Wainess R, Burney RE. Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg. 2008;32(5):795–9.
doi: 10.1007/s00268-007-9427-2
pubmed: 18235984
Rapaport D, Ziv Y, Rubin M, Huminer D, Dintsman M, Primary hyperparathyroidism in children. J Pediatr Surg. 1986;21(5):395–7.
doi: 10.1016/S0022-3468(86)80505-X
pubmed: 3712190
Joshua B, Feinmesser R, Ulanovski D, Gilat H, Sulkes J, Eshed V, et al. Primary hyperparathyroidism in young adults. Otolaryngol Head Neck Surg. 2004;131(5):628–32.
doi: 10.1016/j.otohns.2004.06.701
pubmed: 15523438
Sneider MS, Solorzano CC, Montano RE, Anello C, Irvin GL III, Lew JI. Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res. 2009;155(1):100–3.
doi: 10.1016/j.jss.2008.07.041
pubmed: 19135685
Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145–58.
doi: 10.1016/S0140-6736(09)60507-9
pubmed: 19595349
Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006;21(1):171–7.
doi: 10.1359/JBMR.050910
pubmed: 16355286
Adam LA, Smith BJ, Calva-Cerqueira D, Howe JR, Lal G. Role for limited neck exploration in young adults with apparently sporadic primary hyperparathyroidism. World J Surg. 2008;32(7):1518–24.
doi: 10.1007/s00268-008-9515-y
pubmed: 18335277
Lawson ML, Miller SF, Ellis G, Filler RM, Kooh SW. Primary hyperparathyroidism in a paediatric hospital. QJM. 1996;89(12):921–32.
doi: 10.1093/qjmed/89.12.921
pubmed: 9015486
Sebag F, Hubbard JG, Maweja S, Misso C, Tardivet L, Henry JF. Negative preoperative localization studies are highly predictive of multiglandular disease in sporadic primary hyperparathyroidism. Surgery. 2003;134(6):1038–41 (discussion 1041-2).
doi: 10.1016/j.surg.2003.07.021
pubmed: 14668738
Kraimps JL, Denizot A, Carnaille B, Henry JF, Proye C, Bacourt F, et al. Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d’Etude des Tumeurs a Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons. World J Surg. 1996;20(7):808–12 (discussion 812-3).
doi: 10.1007/s002689900123
pubmed: 8678955
Gertner ME, Kebebew E. Multiple endocrine neoplasia type 2. Curr Treat Options Oncol. 2004;5(4):315–25.
doi: 10.1007/s11864-004-0022-6
pubmed: 15233908
Yip L, Ogilvie JB, Challinor SM, Salata RA, Thull DL, Yim JH, et al. Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism. Surgery. 2008;144(6):1002–6 (discussion 1006-7).
doi: 10.1016/j.surg.2008.07.030
pubmed: 19041010
Miedlich S, Lohmann T, Schneyer U, Lamesch P, Paschke R. Familial isolated primary hyperparathyroidism—a multiple endocrine neoplasia type 1 variant? Eur J Endocrinol. 2001;145(2):155–60.
doi: 10.1530/eje.0.1450155
pubmed: 11454510
Kandil E, Alabbas HH, Lum YW, Tufaro AP. Familial isolated primary hyperparathyroidism with double adenoma. South Med J. 2010;103(3):236–8.
doi: 10.1097/SMJ.0b013e3181d0fe11
pubmed: 20134367
Barry MK, Van Heerden JA, Grant CS, Thompson GB, Khosla S. Is familial hyperparathyroidism a unique disease? Surgery. 1997;122(6):1028–33.
doi: 10.1016/S0039-6060(97)90205-1
pubmed: 9426416